Introduction

Sep 5, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Introduction

Introduction A variety of substances of endogenous and exogenous origin, when carried to the regional lymph nodes, trigger cellular reactions. The histiocytes, cells endowed with phagocytic ability, are the main…

read more

Drug-induced Lymphadenopathy

Sep 5, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Drug-induced Lymphadenopathy

Drug-induced Lymphadenopathy Definition Lymphadenopathy that can mimic malignant lymphoma associated with drug therapy, usually as a result of a hypersensitivity reaction. A wide variety of drugs can induce lymphadenopathy (Table…

read more

Castleman Lymphadenopathy

Sep 5, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Castleman Lymphadenopathy

Castleman Lymphadenopathy Definition In the original reports by Castleman et al. (1,2), Castleman disease (CD) was described as a large, benign, asymptomatic mass involving mediastinal lymph nodes. Fifty years later,…

read more

Introduction

Sep 5, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Introduction

Introduction A variety of vascular disorders may affect the lymph nodes, resulting in ischemic infarction, benign vascular prolife-rations, or malignant vascular neoplasms. Lymph nodes are well vascularized, and therefore ischemic…

read more

Drug-Induced Lymphadenopathy: Methotrexate

Sep 5, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Drug-Induced Lymphadenopathy: Methotrexate

Drug-Induced Lymphadenopathy: Methotrexate Definition Lymphoproliferative disorders associated with methotrexate therapy, usually administered to patients with connective tissue diseases. Introduction Patients with immunodeficiency have an increased risk of lymphoproliferative disorders, in…

read more

Tumor-Reactive Lymphadenopathy

Sep 5, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Tumor-Reactive Lymphadenopathy

Tumor-Reactive Lymphadenopathy Definition Reactive, usually enlarged, regional lymph nodes draining tumor areas. Pathogenesis Regional lymph nodes tributary to tumor-bearing organs are considered anatomic barriers to tumor spread. They are also…

read more

Introduction

Sep 5, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Introduction

Introduction Lymphadenopathies may occur in patients treated with a variety of immunomodulatory drugs. Drugs such as prednisone, azathioprine, methotrexate, cyclosporine, and others are used to diminish the symptoms of hyperimmune…

read more

Lymphadenopathies of Salivary Glands

Sep 5, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Lymphadenopathies of Salivary Glands

Lymphadenopathies of Salivary Glands Definition Lymphadenitides and lymphadenopathies of salivary glands, lymphoid characterized by lymphoepithelial lesions (LEL). Pathogenesis Normally, lymphoid tissues are intimately associated with salivary glands in various forms…

read more

Dermatopathic Lymphadenopathy

Sep 5, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Dermatopathic Lymphadenopathy

Dermatopathic Lymphadenopathy Definition Reactive paracortical hyperplasia of lymph node characterized by an increased number of interdigitating dendritic cells, Langerhans cells, and histiocytes with cytoplasmic melanin deposits and lipid vacuoles. These…

read more

Rheumatoid Lymphadenopathy

Sep 5, 2016 by in PATHOLOGY & LABORATORY MEDICINE Comments Off on Rheumatoid Lymphadenopathy

Rheumatoid Lymphadenopathy Definition Lymphadenopathy accompanying rheumatoid arthritis (RA). Epidemiology Rheumatoid arthritis is common disease, affecting 0.8% of the world’s population (1). Approximately 2 million people in the United States have…

read more
Get Clinical Tree app for offline access